Product Description
The global robotic radiosurgery system market was valued at $350 million in 2024. This is expected to increase over the forecast period at a CAGR of 11.1% to reach $720 million.
The full report suite on the global market for robotic radiosurgery systems includes two segments: capital equipment and services and maintenance revenue. Regional volumes of robotic radiosurgery procedures are also reported.
This report includes data for 65 countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
The number of cancer cases worldwide are steadily increasing and are projected to continue to rise due to a number of factors, including population increase, smoking, stress, alcohol use, poor nutrition, and excess body weight. The World Health Organization (WHO) estimates that there will be more than 35 million new cases of cancer, which is a 77% increase over the 20 million cases that were anticipated in 2022. There are various procedures and drugs used to treat cancer, depending on the type and stage of the disease. These include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, and others. Published studies indicate that radiation therapy contributes approximately 40% to curative cancer treatments. However, it is estimated that the global utilization rate of radiation therapy remains below 50%.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL ROBOTIC RADIOSURGERY SYSTEM MARKET TRENDS
In 2024, North America had the largest share of the overall robotic radiosurgery system market, followed by Western Europe, while Africa had the smallest share out of all regions involved in the market. Over the forecast period, all regions are expected to experience a double-digit growth, except North America and Asia-Pacific. Though Asia-Pacific is set to experience the slowest growth rate in overall market value, it is expected to have the strongest growth rate in terms of procedures.
GLOBAL ROBOTIC RADIOSURGERY SYSTEM MARKET SHARE INSIGHTS
- Accuray is leading the robotic radiosurgery system market with its CyberKnife®. In October 2020, Accuray announced a partnership with Brainlab to expand the scope of CyberKnife® into the neuro-radiosurgery market. Brainlab offers its product line of Brainlab Elements, which are software modules that serve multiple clinical specialties. These software modules enhance the CyberKnife® system by providing precise, automated, customized preoperative planning tools. In June 2022, Accuray announced a partnership with Limbus AI Inc., a Canadian company that creates cancer radiation therapy that makes use of artificial intelligence. The companies plan to create a solution using combined technology to provide enhanced cancer care to patients.
- Zap Surgica is a minor competitor in the market. Zap Surgical Systems, a California-based start-up founded in 2014, is a minor competitor in the stereotactic radiosurgery system market. The company has designed and developed the Zap-X® Gyroscopic Radiosurgery® platform, a self-shielded radiotherapy device for treating benign and malignant conditions in the brain, head and neck regions. The Zap-X® Gyroscopic Radiosurgery® system allows for treatment planning and image-guided stereotactic radiosurgery and radiotherapy. The system is not a robot but features a robotic component: the robotic table. The system provides precise beam positioning by accelerator rotations and accurate movements of the robotic table. The average price of the Zap-X® Gyroscopic Radiosurgery® system is more affordable than Accuray’s CyberKnife® and is estimated to cost less than $2 million.
GLOBAL ROBOTIC RADIOSURGERY SYSTEM MARKET SEGMENTATION SUMMARY
- Capital Equipment Market
- Services Revenue and Maintenance Revenue Market
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast Period | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Data | Procedure Numbers, Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
|
